101 related articles for article (PubMed ID: 15686482)
1. A truncated isoform of pyroglutamyl aminopeptidase II produced by exon extension has dominant-negative activity.
Chávez-Gutiérrez L; Bourdais J; Aranda G; Vargas MA; Matta-Camacho E; Ducancel F; Segovia L; Joseph-Bravo P; Charli JL
J Neurochem; 2005 Feb; 92(4):807-17. PubMed ID: 15686482
[TBL] [Abstract][Full Text] [Related]
2. Pyroglutamyl peptidase II inhibition enhances the analeptic effect of thyrotropin-releasing hormone in the rat medial septum.
Lazcano I; Uribe RM; Martínez-Chávez E; Vargas MA; Matziari M; Joseph-Bravo P; Charli JL
J Pharmacol Exp Ther; 2012 Jul; 342(1):222-31. PubMed ID: 22532627
[TBL] [Abstract][Full Text] [Related]
3. Homology modeling and site-directed mutagenesis of pyroglutamyl peptidase II. Insights into omega-versus aminopeptidase specificity in the M1 family.
Chávez-Gutiérrez L; Matta-Camacho E; Osuna J; Horjales E; Joseph-Bravo P; Maigret B; Charli JL
J Biol Chem; 2006 Jul; 281(27):18581-90. PubMed ID: 16611635
[TBL] [Abstract][Full Text] [Related]
4. Acute administration of alcohol modulates pyroglutamyl amino peptidase II activity and mRNA levels in rat limbic regions.
de Gortari P; Romero F; Cisneros M; Joseph-Bravo P
Neurochem Int; 2005 Mar; 46(4):347-56. PubMed ID: 15707699
[TBL] [Abstract][Full Text] [Related]
5. Anterior pituitary pyroglutamyl peptidase II activity controls TRH-induced prolactin release.
Cruz R; Vargas MA; Uribe RM; Pascual I; Lazcano I; Yiotakis A; Matziari M; Joseph-Bravo P; Charli JL
Peptides; 2008 Nov; 29(11):1953-64. PubMed ID: 18703099
[TBL] [Abstract][Full Text] [Related]
6. NMDA receptor up-regulates pyroglutamyl peptidase II activity in the rat hippocampus.
Rodríguez-Molina V; Vargas MA; Joseph-Bravo P; Charli JL
Neurosci Lett; 2009 Jan; 449(3):211-4. PubMed ID: 19013213
[TBL] [Abstract][Full Text] [Related]
7. TRH inactivation in the extracellular compartment: role of pyroglutamyl peptidase II.
Charli JL; Vargas MA; Cisneros M; de Gortari P; Baeza MA; Jasso P; Bourdais J; Peréz L; Uribe RM; Joseph-Bravo P
Neurobiology (Bp); 1998; 6(1):45-57. PubMed ID: 9713831
[TBL] [Abstract][Full Text] [Related]
8. 3,3',5'-triiodo-L-thyronine reduces efficiency of mRNA knockdown by antisense oligodeoxynucleotides: a study with pyroglutamyl aminopeptidase II in adenohypophysis.
Cruz R; Chávez-Gutiérrez L; Joseph-Bravo P; Charli JL
Oligonucleotides; 2004; 14(3):176-90. PubMed ID: 15625913
[TBL] [Abstract][Full Text] [Related]
9. Chronic ethanol or glucose consumption alter TRH content and pyroglutamyl aminopeptidase II activity in rat limbic regions.
de Gortari P; Cisneros M; Joseph-Bravo P
Regul Pept; 2005 Apr; 127(1-3):141-50. PubMed ID: 15680480
[TBL] [Abstract][Full Text] [Related]
10. Thyrotropin-releasing hormone regulates the diurnal variation of pyroglutamyl aminopeptidase II activity in the male rat adenohypophysis.
Angel Vargas M; Uribe RM; Cisneros M; Romero F; González S; Joseph-Bravo P; Charli JL
Eur J Endocrinol; 2002 Sep; 147(3):363-9. PubMed ID: 12213674
[TBL] [Abstract][Full Text] [Related]
11. Thyrotropin-releasing hormone downregulates pyroglutamyl peptidase II activity in adenohypophyseal cells.
Vargas MA; Joseph-Bravo P; Charli JL
Neuroendocrinology; 1994 Sep; 60(3):323-30. PubMed ID: 7969791
[TBL] [Abstract][Full Text] [Related]
12. Rapid down regulation of pyroglutamyl peptidase II activity by arachidonic acid in primary cultures of adenohypophyseal cells.
Baeza MA; Ponce G; Joseph-Bravo P; Charli JL
Life Sci; 2001 Mar; 68(17):2051-60. PubMed ID: 11388706
[TBL] [Abstract][Full Text] [Related]
13. Purification of a specific inhibitor of pyroglutamyl aminopeptidase II from the marine annelide Hermodice carunculata. in vivo effects in rodent brain.
Pascual I; Gil-Parrado S; Cisneros M; Joseph-Bravo P; Díaz J; Possani LD; Charli JL; Chávez M
Int J Biochem Cell Biol; 2004 Jan; 36(1):138-52. PubMed ID: 14592539
[TBL] [Abstract][Full Text] [Related]
14. Identification and expression analysis of an N-terminally truncated isoform of human PDGF-C.
Zhao J; Liu Z; Liu T; Nilsson S; Nistér M
Exp Cell Res; 2008 Aug; 314(14):2529-43. PubMed ID: 18588873
[TBL] [Abstract][Full Text] [Related]
15. Amygdala kindling differentially regulates the expression of the elements involved in TRH transmission.
de Gortari P; Uribe RM; García-Vázquez A; Aguilar-Valles A; Martínez A; Valdés A; Charli JL; Fernández-Guardiola A; Joseph-Bravo P
Neurochem Int; 2006 Jan; 48(1):31-42. PubMed ID: 16213061
[TBL] [Abstract][Full Text] [Related]
16. Thyrotropin-releasing hormone-induced down-regulation of pyroglutamyl aminopeptidase II activity involves L-type calcium channels and cam kinase activities in cultures of adenohypophyseal cells.
Vargas MA; Cisneros M; Joseph-Bravo P; Charli JL
J Neuroendocrinol; 2002 Mar; 14(3):184-93. PubMed ID: 11999717
[TBL] [Abstract][Full Text] [Related]
17. Mediobasal hypothalamic and adenohypophyseal TRH-degrading enzyme (PPII) is down-regulated by zinc deficiency.
Alvarez-Salas E; Alcántara-Alonso V; Matamoros-Trejo G; Vargas MA; Morales-Mulia M; de Gortari P
Int J Dev Neurosci; 2015 Nov; 46():115-24. PubMed ID: 26315400
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning and characterization of two novel truncated isoforms of human Na+/Ca2+ exchanger 3, expressed in fetal brain.
Lindgren RM; Zhao J; Heller S; Berglind H; Nistér M
Gene; 2005 Mar; 348():143-55. PubMed ID: 15777725
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of the phosphinic analogue of thyrotropin releasing hormone.
Matziari M; Bauer K; Dive V; Yiotakis A
J Org Chem; 2008 Nov; 73(21):8591-3. PubMed ID: 18826326
[TBL] [Abstract][Full Text] [Related]
20. Multiple hypothalamic factors regulate pyroglutamyl peptidase II in cultures of adenohypophyseal cells: role of the cAMP pathway.
Vargas MA; Bourdais J; Sanchez S; Uriostegui B; Moreno E; Joseph-Bravo P; Charli JL
J Neuroendocrinol; 1998 Mar; 10(3):199-206. PubMed ID: 9576608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
